 
        





| Catalog No. | HV162016 | 
|---|---|
| Species reactivity | Human | 
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | 
| Host species | Human | 
| Isotype | IgG2-lambda | 
| Expression system | Mammalian Cells | 
| Clonality | Monoclonal | 
| Target | FzE1, Frizzled-1, hFz1, Fz-1, FZD1 | 
| Endotoxin level | Please contact the lab for this information. | 
| Purity | >95% purity as determined by SDS-PAGE. | 
| Purification | Protein A/G purified from cell culture supernatant. | 
| Accession | Q9UP38 | 
| Form | Liquid | 
| Storage buffer | 0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. | 
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. | 
| Alternate Names | OMP-18R5, 1345009-45-1 | 
| Background | Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab can be studied against cancers through direct actions on tumor cells, including CSCs, and effects on the stroma, such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma. • Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation., PMID:29482174 • The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway., PMID:14739301 • Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway., PMID:22484497 • Functional and association analysis of frizzled 1 (FZD1) promoter haplotypes with femoral neck geometry., PMID:20051274 • Functional characterization of genetic variation in the Frizzled 1 (FZD1) promoter and association with bone phenotypes: more to the LRP5 story?, PMID:18715140 • Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1., PMID:27695039 • Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response., PMID:10557084 • Oligodendroglial ring finger protein Rnf43 is an essential injury-specific regulator of oligodendrocyte maturation., PMID:34390652 • miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1., PMID:27643554 • FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells., PMID:24814288 | 
| Note | For research use only. Not suitable for clinical or therapeutic use. | 

SDS-PAGE for Research Grade Vantictumab.

SEC-HPLC detection for Research Grade Vantictumab.

Western blot analysis was performed using anti-FZD7  monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human FZD7  (Catalog No: HF587011)
Lane 2: negative control




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com






+86-027-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
 
                 中文
 中文 English
 English